Lilly seeking to join lawsuit over compounded GLP-1 drugs
by Contributor since / Followers
3 days ago
jetcityimage
Eli Lilly (NYSE:LLY) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA’s determination that weight-loss and diabetes drugs such as Lilly’s (NYSE:LLY) tirzepatide are no longer in short supply.
